IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q4 2020 Holdings

Filed 2021-02-16 | 26 holdings | $498.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals, Inc.(AVIR)COM04683R106$234.6M5,615,65947.1%
Arcutis Biotherapeutics, Inc.(ARQT)COM03969K108$111.9M3,979,29222.5%
Annexon Inc(ANNX)COM03589W102$81.1M3,241,62816.3%
C4 Therapeutics, Inc.(CCCC)COM STK12529R107$54.4M1,642,20910.9%
Crinetics Phamaceuticals(CRNX)COM22663K107$15.1M1,071,4283.0%
Springworks Therapeutics IncCOM85205L107$528.0K7,281,3070.1%
Mersana TherapeuticsCOM59045L106$91.7K3,445,6670.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$67.9K3,080,2370.0%
Syros Pharmaceuticals, Inc.COM87184Q107$62.8K5,785,0360.0%
Solid Biosciences IncCOM83422E105$53.5K7,060,3530.0%
Dynavax Technologies CorpCOM268158901$48.5K10,895,7730.0%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$42.2K1,284,3140.0%
Constellation Pharmaceuticals, Inc.(CNST)COM210373106$40.3K1,400,0000.0%
Aptinyx IncCOM03836N103$30.8K8,891,7580.0%
Kymera Therapeutics Inc.(KYMR)COM501575104$29.7K479,6050.0%
Aeglea BIO Therapeutics(AGLEUSD)COM00773J103$21.2K2,700,0000.0%
Marinus Pharmaceuticals IncCOM56854Q101$17.5K1,431,0580.0%
Therapeutics Acquisition CORCOM CL A88339T103$13.9K1,000,0000.0%
Arya Sciences Acquisition Corp IIICOM CL AG3166W106$10.9K1,000,0000.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$10.6K1,648,4850.0%
Savara Inc(SVRA)COM805111101$5.9K5,128,5930.0%
Bctg Acquisition CorpCOM05492W103$5.7K500,0000.0%
Bcls Acquisition CorpCOM CL AG0904B105$5.4K487,5000.0%
Frazier Lifesciences Acquisition CorpUNIT 12/09/2025G3710A121$3.1K300,0000.0%
Jiya Acquisition CorpCOM CL A47760M102$3.1K300,0000.0%
Helix Acquisition CorpCOM CL AG4444C102$2.8K250,0000.0%